1 / 10

Chronic Pain Treatment Market Size, Growth, Development and Demand Forecast to 2030

The main growth factors for the worldwide chronic pain treatment market are the growing geriatric population, rising elderly population, and rising prevalence of chronic health disorders. The sector will generate USD 162,175.2 million in sales in 2030 as a result of the aforementioned causes, as per P&S Intelligence.

psmarket
Download Presentation

Chronic Pain Treatment Market Size, Growth, Development and Demand Forecast to 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chronic Pain Treatment Market Size, Share, Growth, Development and Demand Forecast to 2030 1 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  2. Over 60% of people in the world will increase from 12% to 22% between 2015 and 2050, as per the WHO. Moreover, a major issue for care facilities is the high prevalence of chronic pain among older residents in nursing homes. Pharmacological, non-pharmacological (physical therapy, such as exercise, foot orthotics, or patellar taping for knee osteoarthritis) and occupational therapies (assistive devices and joint protection education) are the main treatments used to treat this condition in the elderly population, which in turn has a positive impact on the need for chronic pain treatment. The main growth factors for the worldwide chronic pain treatment market are the growing geriatric population, rising elderly population, and rising prevalence of chronic health disorders. The sector will generate USD 162,175.2 million in sales in 2030 as a result of the aforementioned causes, as per P&S Intelligence. One of the biggest healthcare burdens on the planet, which affects both high- income and low- and middle-income countries, is the increased prevalence of chronic diseases. Moreover, osteoarthritis, fibromyalgia, cancer, sickle-cell anemia, and autoimmune disorders (rheumatoid arthritis) are a few examples of chronic diseases that call for therapeutic intervention for effective pain management. Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/chronic-pain- treatment-market/report-sample Cancer Pain Categories Will See Rapid Growth According to predictions, the category of cancer pain will rise the fastest in the future. Cancer is one of the top causes of death worldwide, according to the NCI. By 2040, it is anticipated that there would be 29.5 million new instances of cancer diagnosed annually, with 16.4 million cancer-related deaths. As a result, the market is being driven by the growing number of cancer survivors because the condition results in severe, prolonged pain. The hospitals category will achieve the highest growth rate in the years to come. Hospitals are the places where pain management procedures are used most frequently, especially for post-surgical pain, where the high cost of monitoring and treating side effects results in the need for pain management treatment and medications. North America Led Market Demand Geographically, North America was the highest revenue generator in the chronic 2 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  3. pain treatment market in 2020 due to the high healthcare spending, developed healthcare infrastructure, and widespread accessibility to cutting-edge medications and medical equipment. On the other hand, the APAC market is anticipated to experience the quickest growth during the forecast period, largely due to the region's expanding elderly population, improved healthcare infrastructure, rising per capita income, and surging cases of chronic pain. Browse full report at: https://www.psmarketresearch.com/market- analysis/chronic-pain-treatment-market Drugs Categories Dominate Market The market for treating chronic pain was dominated by the medication category. This is partly because several chronic pain conditions, such as excruciating headaches or migraine pain, lower back pain, and facial discomfort, are becoming more common. Additionally, the market for painkiller medications will grow due to the increasing senior population worldwide, sedentary lifestyle, and increase in surgical operations. According to the application, the musculoskeletal category accounted for the largest share of the market for treating chronic pain. The high prevalence of musculoskeletal conditions including fibromyalgia, osteoarthritis, and rheumatoid arthritis is mostly to blame for this. Market Size Breakdown by Segment Based on Product Drugs • oOpioids oNon-steroidal anti-inflammatory drugs (NSAIDs) oAnticonvulsants oAntidepressants oOthers Devices • oNeurostimulation devices Spinal cord stimulation (SCS) devices Transcutaneous electrical nerve stimulation (TENS) devices Others ▪ ▪ ▪ 3 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  4. oAnalgesic infusion pumps oAblation devices Radiofrequency ablation devices Cryoablation devices ▪ ▪ oOthers Based on Indication Neuropathic Pain Arthritis Pain Chronic Back Pain Cancer Pain Migraine Fibromyalgia Others Based on Application Musculoskeletal Neuropathy Oncology Others Based on Distribution Channel Direct Indirect Based on End User Hospitals Clinics Nursing Homes Research Centers & Universities Others Geographical Analysis North America Chronic Pain Treatment Market • • • • • • • • • • • • • • • • • • • oBy product oBy indication oBy application oBy distribution channel oBy end user oBy country – U.S. and Canada U.S. chronic pain treatment market ▪ 4 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  5. By product By indication By application By distribution channel By end user Canada chronic pain treatment market By product By indication By application By distribution channel By end user Europe Chronic Pain Treatment Market ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ • oBy product oBy indication oBy application oBy distribution channel oBy end user oBy country – Germany, France, U.K., Italy, Spain, Netherlands, Russia, Sweden, Switzerland, and Rest of Europe Germany chronic pain treatment market By product By indication By application By distribution channel By end user France chronic pain treatment market By product By indication By application By distribution channel By end user U.K. chronic pain treatment market By product By indication By application By distribution channel ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ 5 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  6. By end user ▪ Italy chronic pain treatment market By product By indication By application By distribution channel By end user Spain chronic pain treatment market By product By indication By application By distribution channel By end user Netherlands chronic pain treatment market By product By indication By application By distribution channel By end user Russia chronic pain treatment market By product By indication By application By distribution channel By end user Sweden chronic pain treatment market By product By indication By application By distribution channel By end user Switzerland chronic pain treatment market By product By indication By application By distribution channel ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ 6 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  7. By end user ▪ Asia-Pacific (APAC) Chronic Pain Treatment Market • oBy product oBy indication oBy application oBy distribution channel oBy end user oBy country – Japan, China, India, Australia, South Korea, and Rest of APAC Japan chronic pain treatment market By product By indication By application By distribution channel By end user China chronic pain treatment market By product By indication By application By distribution channel By end user India chronic pain treatment market By product By indication By application By distribution channel By end user Australia chronic pain treatment market By product By indication By application By distribution channel By end user South Korea chronic pain treatment market By product By indication By application ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ 7 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  8. By distribution channel By end user ▪ ▪ Latin America (LATAM) Chronic Pain Treatment Market • oBy product oBy indication oBy application oBy distribution channel oBy end user oBy country – Brazil, Mexico, and Rest of LATAM Brazil chronic pain treatment market By product By indication By application By distribution channel By end user Mexico chronic pain treatment market By product By indication By application By distribution channel By end user Middle East and Africa (MEA) Chronic Pain Treatment Market ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ • oBy product oBy indication oBy application oBy distribution channel oBy end user oBy country – Saudi Arabia, South Africa, and Rest of MEA Saudi Arabia chronic pain treatment market By product By indication By application By distribution channel By end user South Africa chronic pain treatment market By product ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ 8 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  9. By indication By application By distribution channel By end user ▪ ▪ ▪ ▪ 9 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  10. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 4 ©P&SIntelligence.Allrightsreserved 10 © Prescient & Strategic Intelligence Private Limited. All rights reserved

More Related